Cyclerion Therapeutics entered an agreement to integrate Medsteer's technology into CYC-126, its lead program in development for treatment-resistant depression.

Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...

A new multi-institution research study shows how artificial intelligence (AI) machine learning combined with electronic health records (EHRs) can predict antidepressant treatment outcomes. “These ...

Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...

A groundbreaking collaboration provides useful advice on a clinically challenging problem. Depression is common in women during the childbearing years, and psychiatrists and obstetricians alike can ...

Shares of Cyclerion Therapeutics climbed after the company entered an agreement to integrate Medsteer's technology into its lead program in development for treatment-resistant depression. The stock ...

One of the most promising areas in precision medicine and health care is the use of artificial intelligence (AI) machine learning as a tool to assist clinicians in predicting patient treatment ...

A new study has found that antidepressant resistance is more common than was thought: 48% of people with depression have tried at least two medications without effect, while 37% have tried four or ...